U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06986603) titled 'Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia' on May 15.
Brief Summary: The purpose of the study is to determine how blood sugar levels in individuals with and without hypoglycemia after bariatric surgery respond to different doses of glucagon, a hormone that is usually present in your body that regulates blood sugar levels. In this study, there will be 4 visits to the clinical research center. In the first visit, medical history and physical exam will be performed, and blood samples will be taken to assess overall health. During visit 2, a continuous glucose monitor will be placed under the skin. (This may be ...